Table 1 Characteristics of patients with... | American Society of Hematology

Table 1

Characteristics of patients with Waldenstrom macroglobulinemia

Patient	Sex	Age, y	IgM, g/dL	BM, %
1	M	60	4.2	70
2	M	70	2.4	80
3	M	59	3.5	80
4	F	73	1.4	70
5	F	77	0.6	30
6	M	75	1.6	60
7	M	79	3.4	70
8	M	59	3.2	60
9	F	54	0.5	0
10	F	69	0.6	0
11	M	71	1.5	40
13	M	69	0.3	5
14	F	73	0.4	50
15	M	79	1.9	70
16	F	76	0.2	10
17	M	77	0.8	5
18	M	62	1.1	20
19	F	78	2	80
20	M	68	0.6	30
21	M	60	1	5
22	M	65	2.5	40
23	F	77	0.8	5
24	M	71	2.7	95
25	M	63	2.1	10
26	M	70	1.3	20
27	F	67	1.3	15

Patient	Sex	Age, y	IgM, g/dL	BM, %
1	M	60	4.2	70
2	M	70	2.4	80
3	M	59	3.5	80
4	F	73	1.4	70
5	F	77	0.6	30
6	M	75	1.6	60
7	M	79	3.4	70
8	M	59	3.2	60
9	F	54	0.5	0
10	F	69	0.6	0
11	M	71	1.5	40
13	M	69	0.3	5
14	F	73	0.4	50
15	M	79	1.9	70
16	F	76	0.2	10
17	M	77	0.8	5
18	M	62	1.1	20
19	F	78	2	80
20	M	68	0.6	30
21	M	60	1	5
22	M	65	2.5	40
23	F	77	0.8	5
24	M	71	2.7	95
25	M	63	2.1	10
26	M	70	1.3	20
27	F	67	1.3	15

Patient	Sex	Age, y	IgM, g/dL	BM, %
1	M	60	4.2	70
2	M	70	2.4	80
3	M	59	3.5	80
4	F	73	1.4	70
5	F	77	0.6	30
6	M	75	1.6	60
7	M	79	3.4	70
8	M	59	3.2	60
9	F	54	0.5	0
10	F	69	0.6	0
11	M	71	1.5	40
13	M	69	0.3	5
14	F	73	0.4	50
15	M	79	1.9	70
16	F	76	0.2	10
17	M	77	0.8	5
18	M	62	1.1	20
19	F	78	2	80
20	M	68	0.6	30
21	M	60	1	5
22	M	65	2.5	40
23	F	77	0.8	5
24	M	71	2.7	95
25	M	63	2.1	10
26	M	70	1.3	20
27	F	67	1.3	15

Patient	Sex	Age, y	IgM, g/dL	BM, %
1	M	60	4.2	70
2	M	70	2.4	80
3	M	59	3.5	80
4	F	73	1.4	70
5	F	77	0.6	30
6	M	75	1.6	60
7	M	79	3.4	70
8	M	59	3.2	60
9	F	54	0.5	0
10	F	69	0.6	0
11	M	71	1.5	40
13	M	69	0.3	5
14	F	73	0.4	50
15	M	79	1.9	70
16	F	76	0.2	10
17	M	77	0.8	5
18	M	62	1.1	20
19	F	78	2	80
20	M	68	0.6	30
21	M	60	1	5
22	M	65	2.5	40
23	F	77	0.8	5
24	M	71	2.7	95
25	M	63	2.1	10
26	M	70	1.3	20
27	F	67	1.3	15

Patient	Sex	Age, y	IgM, g/dL	BM, %
1	M	60	4.2	70
2	M	70	2.4	80
3	M	59	3.5	80
4	F	73	1.4	70
5	F	77	0.6	30
6	M	75	1.6	60
7	M	79	3.4	70
8	M	59	3.2	60
9	F	54	0.5	0
10	F	69	0.6	0
11	M	71	1.5	40
13	M	69	0.3	5
14	F	73	0.4	50
15	M	79	1.9	70
16	F	76	0.2	10
17	M	77	0.8	5
18	M	62	1.1	20
19	F	78	2	80
20	M	68	0.6	30
21	M	60	1	5
22	M	65	2.5	40
23	F	77	0.8	5
24	M	71	2.7	95
25	M	63	2.1	10
26	M	70	1.3	20
27	F	67	1.3	15

Patient	Sex	Age, y	IgM, g/dL	BM, %
1	M	60	4.2	70
2	M	70	2.4	80
3	M	59	3.5	80
4	F	73	1.4	70
5	F	77	0.6	30
6	M	75	1.6	60
7	M	79	3.4	70
8	M	59	3.2	60
9	F	54	0.5	0
10	F	69	0.6	0
11	M	71	1.5	40
13	M	69	0.3	5
14	F	73	0.4	50
15	M	79	1.9	70
16	F	76	0.2	10
17	M	77	0.8	5
18	M	62	1.1	20
19	F	78	2	80
20	M	68	0.6	30
21	M	60	1	5
22	M	65	2.5	40
23	F	77	0.8	5
24	M	71	2.7	95
25	M	63	2.1	10
26	M	70	1.3	20
27	F	67	1.3	15

Patient	Sex	Age, y	IgM, g/dL	BM, %
1	M	60	4.2	70
2	M	70	2.4	80
3	M	59	3.5	80
4	F	73	1.4	70
5	F	77	0.6	30
6	M	75	1.6	60
7	M	79	3.4	70
8	M	59	3.2	60
9	F	54	0.5	0
10	F	69	0.6	0
11	M	71	1.5	40
13	M	69	0.3	5
14	F	73	0.4	50
15	M	79	1.9	70
16	F	76	0.2	10
17	M	77	0.8	5
18	M	62	1.1	20
19	F	78	2	80
20	M	68	0.6	30
21	M	60	1	5
22	M	65	2.5	40
23	F	77	0.8	5
24	M	71	2.7	95
25	M	63	2.1	10
26	M	70	1.3	20
27	F	67	1.3	15

Patient	Sex	Age, y	IgM, g/dL	BM, %
1	M	60	4.2	70
2	M	70	2.4	80
3	M	59	3.5	80
4	F	73	1.4	70
5	F	77	0.6	30
6	M	75	1.6	60
7	M	79	3.4	70
8	M	59	3.2	60
9	F	54	0.5	0
10	F	69	0.6	0
11	M	71	1.5	40
13	M	69	0.3	5
14	F	73	0.4	50
15	M	79	1.9	70
16	F	76	0.2	10
17	M	77	0.8	5
18	M	62	1.1	20
19	F	78	2	80
20	M	68	0.6	30
21	M	60	1	5
22	M	65	2.5	40
23	F	77	0.8	5
24	M	71	2.7	95
25	M	63	2.1	10
26	M	70	1.3	20
27	F	67	1.3	15